DS

David Sinclair

Founder of Fully Aligned Co

Greater Boston

Overview 

David Sinclair is a Professor at Harvard Medical School with expertise in cell biology, biotechnology, genetics, cancer research, and drug development. He has co-founded multiple successful biotech startups, served as a board member, advisor, and investor in various life sciences companies, and contributed significantly to the field of aging research as Co-Editor in Chief of Aging.

Work Experience 

  • Professor

    1999 - Current

  • Co-Editor in Chief

    2008

    A scientific journal that publishes papers in all disciplines relevant to aging.

Aging is a journal that publishes research papers on aging and age-related diseases.

  • Board Member, Investor, Advisor

    2017

    Life Biosciences is a leader in developing pharmaceuticals based on the science of aging. It is the parent company of Senolytic Therapeutics, Jumpstart Fertility, Continuum Biosciences, Selphagy, Animal Biosciences, Lua Communications.

Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.

Raised $206,774,925.00 from Alpha Wave Ventures, Abundance Partners and George Godula.

  • Co-founder, Board Member, Scientific Advisor, Investor

    2013

  • Co-Founder

    2012

EdenRoc Sciences is a privately-backed holding and operating company that manages bioscience and pharmaceutical startup companies.

Raised $240,838,629.00.

  • Co-Founder

    2022

    In 2022, Professor David A. Sinclair, A.O., Ph.D. and Serena Poon CN, CHC, CHN co-founded Fully Aligned Co, LLC, a conscious company backed by research, with the intentions of Bridging the Science and Soul for Well-Being™. As world-renowned experts in health, wellness and longevity, David and Serena produce content, products and services designed to democratize access to knowledge and tools that enhance well-being and maximize healthy lifespan

  • Co-Founder

    2018

    Maker of Leap Years (R) supplements to increase vitality and the healthy years of life for companion animals.

Animal Bioscience is a pet platform.

Raised $2,333,528.00 from Longevitytech.fund.

  • Co-founder, Board member

    2020

  • Co-Founder, Board Member, Advisor, Investor

    2016

  • Scientific Advisor, Investor

    2011

    Personalized Health IT

InsideTracker features its platform that analyzes and tracks key biochemical and physiological markers.

Raised $18,200,000.00 from BASF Venture Capital, OurCrowd, PeakBridge and Cornucopian Capital.

Articles About David

Relevant Websites